When Davos and Bilderberg messenger boys look at The Grand Chessboard, they realize that their era of perpetual free lunch is over.
Discreetly, as under the radar as a looming virus, the 68th Bilderberg meeting is currently underway in Washington, D.C. Nothing to see here. No conspiracy theories about a “secret cabal”, please. This is just a docile, “diverse group of political leaders and experts” having a chat, a laugh, and a bubbly.
Still, one cannot but notice that the choice of venue speaks more volumes than the entire – burned to the ground – Library of Alexandria. In the year heralding the explosion of a much-awaited NATO vs. Russia proxy war, discussing its myriad ramifications does suit the capital of the Empire of Lies, much more than Davos a few weeks ago, where one Henry Kissinger sent them into a frenzy by advancing the necessity of a toxic compromise named “diplomacy”.
The list of Bilderberg 2022 participants is a joy to peruse. Here are just some of the stalwarts:
James Baker, Consigliere extraordinaire, now a mere Director of the Office of Net Assessment at the Pentagon.
José Manuel Barroso, former head of the European Commission, later the recipient of a golden parachute in the form of Chairman of Goldman Sachs International.
Albert Bourla, the Pfizer Big Guy.
William Burns, CIA director.
Kurt Campbell, the guy who invented the Obama/Hillary “pivot to Asia”, now White House Coordinator for Indo-Pacific.
Mark Carney, former Bank of England, one of the designers of the Great Reset, now Vice Chair of Brookfield Asset Management.
Henry Kissinger, The Establishment’s Voice (or a war criminal: take your pick).
Charles Michel, President of the European Council.
Minton Beddoes, Editor-in-Chief of The Economist, which will duly relay all major Bilderberg directives in the magazine’s upcoming cover stories.
David Petraeus, certified loser of endless surges and Chairman of KKR Global Institute.
Mark Rutte, hawkish Prime Minister of the Netherlands.
Jens Stoltenberg, NATO top parrot, sorry, secretary-general.
Jake Sullivan, Director of the National Security Council.
The ideological and geopolitical affiliations of these members of the “diverse group” need no further elaboration. It gets positively sexier when we see what they will be discussing.
Among other issues we find “NATO challenges”; “Indo-Pacific realignment”; “continuity of government and economy” (Conspirationists: continuity in case of nuclear war?); “disruption of global financial system” (already on); “post-pandemic health” (Conspirationists: how to engineer the next pandemic?); “trade and deglobalization”; and of course, the choice wagyu beef steaks: Russia and China.
As Bilderberg follows Chatham House Rules, mere mortals won’t have a clue of what they actually “proposed” or approved, and none of the participants will be allowed to talk about it with anyone else. One of my top New York sources, with direct access to most of the Masters of the Universe, loves to quip that Davos and Bilderberg are just for the messenger boys: the guys who really run the show don’t even bother to show up, ensconced in their uber-private meetings in uber-private clubs, where the real decisions are made.
Still, anyone following in some detail the rotten state of the “rules-based international order” will have a pretty good idea about the 2022 Bilderberg chatter.
What the Chinese say
Secretary of State Little Blinken – Sullivan’s sidekick in the ongoing Crash Test Dummy administration’s Dumb and Dumber remake – has recently claimed that China “supports” Russia on Ukraine instead of remaining neutral.
What really matters here is that Little Blinken is implying that Beijing wants to destabilize Asia-Pacific – which is a notorious absurdity. Yet that’s the master narrative that must pave the way for the US to muscle up its “Indo-Pacific” concoction. And that’s the briefing Sullivan and Kurt Campbell will be delivering to the “diverse group”.
Davos – with its new self-billed mantra, “The Great Narrative” – completely excluded Russia. Bilderberg is mostly about containment of China – which after all is the number one existential threat to the Empire of Lies and its satrapies.
Rather than wait for Bilderberg morsels dispensed by The Economist, it’s much more productive to check out what a cross-section of fact-based Chinese intelligentsia thinks about the new “collective West” racket.
Let’s start with Justin Lin Yifu, former Chief Economist of the World Bank and now Dean of the Institute of New Structural Economics at Peking University, and Sheng Songcheng, former head of the Financial Survey and Statistic Dept. a the Bank of China.
They advance that if China achieves “dynamic zero infection” on Covid-19 by the end of May (that actually happened: see the end of the Shanghai lockdown), China’s economy may grow by 5.5% in 2022.
They dismiss the imperial attempt to establish an “Asian version of NATO”: “As long as China continues to grow at a higher rate and to open up, European and ASEAN countries would not participate in the US’s decoupling trap so as to ensure their economic growth and job creation.”
Three academics from the Shanghai Institute of International Studies and Fudan University touch on the same point: the American-announced “Indo-Pacific Economic Framework”, supposed to be the economic pillar of the Indo-Pacific strategy, is nothing but a cumbersome attempt to “weaken the internal cohesion and regional autonomy of ASEAN.”
Liu Zongyi stresses that China’s position at the heart of the vastly inter-connected Asian supply chains “has been consolidated”, especially now with the onset of the largest trade deal on the planet, the Regional Comprehensive Economic Partnership (RCEP).
Chen Wengling, Chief Economist of a think tank under the key National Development and Reform Commission, notes the “comprehensive ideological and technological war against China” launched by the Americans.
But he’s keen to stress how they are “not ready for a hot war as the US and Chinese economies are so closely linked.” The crucial vector is that “the US has not yet made substantial progress in strengthening its supply chain focusing on four key fields including semiconductors.”
Chen worries about “China’s energy security”; “China’s silence” on US sanctions on Russia, which “may result in US retaliation”; and crucially, how “China’s plan of building the Belt and Road Initiative (BRI) with Ukraine and EU countries will be affected.” What will happen in practice is BRI will be privileging economic corridors across Iran and West Asia, as well as the Maritime Silk Road, instead of the Trans-Siberian corridor across Russia.
It’s up to Yu Yongding, from the Chinese Academy of Social Sciences (CASS) and a former member of the Monetary Policy Committee of the Central Bank, to go for the jugular, noting how” the global financial system and the US dollar have been weaponized into geopolitical tools. The nefarious behavior of the US in freezing foreign exchange reserves has not only seriously damaged the international credibility of the US but has also shaken the credit foundation of the dominant international financial system in the West.”
He expresses the consensus among Chinese intel, that “if there is a geopolitical conflict between the US and China, then China’s overseas assets will be seriously threatened, especially its huge reserves. Therefore, the composition of China’s external financial assets and liabilities urgently needs to be adjusted and the portion of US dollar denominated assets in its reserves portfolio should be reduced.”
This chessboard sucks
A serious debate is raging across virtually all sectors of Chinese society on the American weaponization of the world financial casino. The conclusions are inevitable: get rid of US Treasuries, fast, by any means necessary; more imports of commodities and strategic materials (thus the importance of the Russia-China strategic partnership); and firmly secure overseas assets, especially those foreign currency reserves.
Meanwhile Bilderberg’s “diverse group”, on the other side of the pond, is discussing, among other things, what will really happen in case they force the IMF racket to blow up (a key plan to implement The Great Reset, or “Great Narrative”).
They are starting to literally freak out with the slowly but surely emergence of an alternative, resource-based monetary/financial system: exactly what the Eurasia Economic Union (EAEU) is currently discussing and designing, with Chinese input.
Imagine a counter-Bilderberg system where a basket of Global South actors, resource-rich but economically poor, are able to issue their own currencies backed by commodities, and finally get rid of their status of IMF hostages. They are all paying close attention to the Russia gas-for-rubles experiment.
And in China’s particular case, what will always matter is loads of productive capital underpinning a massive, extremely deep industrial and civil infrastructure.
No wonder Davos and Bilderberg messenger boys, when they look at The Grand Chessboard, are filled with dread: their era of perpetual free lunch is over. What would delight cynics, skeptics, neoplatonists and Taoists galore is that it was Davos-Bilderberg Men (and Women) who actually boxed themselves into zugzwang.
All dressed up – with nowhere to go. Even JP Morgan’s Jamie Dimon – who didn’t even bother to go to Bilderberg – is scared, saying an economic “hurricane” is coming. And overturning the chessboard is no remedy: at best that may invite a ceremonious tuxedo visit by Mr. Sarmat and Mr. Zircon carrying some hypersonic bubbly.
Here We Go Again – Monkeypox Communications Challenges
In February 2020 I published a blog posting – Emerging Pathogens, Communications – that encapsulated my observations and learnings from my years work…
In February 2020 I published a blog posting – Emerging Pathogens, Communications – that encapsulated my observations and learnings from my years work in the early years of the HIV/AIDS pandemic in the early 1980s. As we sit, possibly, on the cusp of another large scale medical challenge with monkeypox, it seemed like a good idea to revisit the topic. When there is a new and scary thing we are facing, medically speaking, there are some truisms regarding the communications environment that can inform strategic thinking about how we talk about it.
- Facts are low, speculation is high – And nature hates a vacuum and there will be many who are willing to fill the void with misinformation. People want facts, and the fact is, facts are in short supply.
- Numbers don’t mean a lot – First of all, they change quickly – and are changing very quickly with monkeypox. In addition, there is often a lack of accurate reporting for many reasons.
- Points of reference will change – What we know, and what we don’t know, will change over time as we get more experience and gain wider understanding. That might seem like a good thing, but in fact, changing stories undermine credibility.
- Fraud potential is high – There are people who will take advantage of the situation and exploit it for political and/or financial gain. That, too, impacts credibility and can confuse people.
- Policy is likely to be ham-handed – Policies may be developed quickly and without adequate information and be based on emotion and bias more than facts. This is another factor that strains credibility.
Monkeypox is not COVID, and COVID was not AIDS. They each present distinct challenges and evoke particular fears and concerns. There are big differences between the three. But they are all viruses. And when it comes to communications challenges there are many commonalities.
First and foremost, in the absence of facts, fear can drive actions. And when a pathogen is newly emerging, facts are greatly outnumbered by questions. The degree to which companies, educators, businesses and service providers may want to prepare to deal with those challenges may depend on where they are, who their stakeholders are, and how big or small they are. At this stage though, better to consider the challenges that may lay before you know, before they present themselves.
It may be that monkeypox is contained early if we are lucky. There are reported signs that transmission may be slowing in the U.K. and the trend in the graph above appears to show some deceleration. That said, the numbers have increased quickly on an extremely steep curve. That means there is an increasing amount of virus out there. The virus has mainly spread among men who have sex with men and transmission is being attributed to skin contact. But the higher the numbers go the greater potential there is for more lateral spread. A presumptive pediatric case was reported last week in California. It is also a virus that can move between people and animals.
Containment depends on systems that are able to screen, test, treat, and prevent (both by means of avoiding circumstances that can enhance transmission and by vaccination). To that end, many things are not in our favor. An extremely splintered approach at federal, state and local levels impacts the coordination of a public health response. We have COVID fatigue in the extreme. And in terms of tools, we do not have a means for screening, meaning we do not know who is infected before they exhibit symptoms which may take several days; the testing situation is complicated because there is no quick, at-home testing like there is for COVID and may be best applied when there are lesions. But people may have other symptoms such as headache, chills, muscle aches, swollen lymph nodes and exhaustion. The only FDA-approved drug to treat is approved for smallpox, but no Monkeypox and has been difficult to access. In terms of prevention, while a vaccine has been developed, supply is very short and it, too, has been hard to get.
Additional challenges include the fact that the course of illness runs two to four weeks. If a person must self-isolate for that length of time it is not only difficult, but there may be unintended consequences. With men who have sex with men comprising the overwhelming majority of cases, a diagnosis is the equivalent of coming out. For many gay men that is not a problem. For many others, who may have wives and children, it can be a very large one, facing a situation that may have both personal and professional peril.
At the present time, there are some states which are reporting higher numbers than others. If the numbers do continue to climb, then a larger number of geographies will be impacted and most likely a wider circle of people, raising the chances that large employers, those in specific sectors, may face communications challenges sooner rather than later such as:
- Travel and hospitality
- Schools and universities
- Institutional settings such as daycare centers, rehab and nursing homes (a case of a daycare workers was reported in Illinois last week)
What to Do
Every business, service or place of public accommodation is different. There is no one-size-fits-all approach to preparation. One must consider the size of the enterprise, the stakeholders and the level of physical contact and interaction with surfaces. That said, there are echos from both AIDS and COVID that shed light into how people may react to the emergence of another communicable condition. A few things to consider:
- Review policies and assess what may need to be changed or amended; this is not just COVID return-to-work policies, but discrimination policies as well. Re-think many of the things you have had to communicate about a virus transmitted by air, and re-fashion to think about surfaces. Monkeypox will present distinct challenges.
- Consider the questions and issues you may face. Can we catch monkeypox using the toilet? Trying on clothes? Do I have to sit next to the gay man? My co-worker says it is eczema, I’m afraid it is Monkeypox. Depending on your business, your clientele, there are different sets of questions that may arise for different settings. Think about what they might be and to what degree you are the one to have to provide the answers.
- Assess the triggers for potential fear and conflict between employees, customers and users of any service.
- Communicating in an environment where what we know changes, and what was certain yesterday may be uncertain tomorrow is always a strain on credibility. Therefore consider integrating reminders to that effect in your communications. What we know now is….
- Gather reliable resources – the obvious ones such as CDC, FDA, and Departments of Health at the state and local levels, but also consider credible grassroots organizations, particularly ones that may resonate with stakeholders, particularly those dealing with gay-related health issues and key medical societies such as the American Society for Microbiology and others.
Many people think that preparation during such a nascent phase of the outbreak is over-reacting. I hope they are right. But having lived through AIDS and COVID, and seen early numbers quickly spell a different story over a very short period of time, one may be well-served to think it through now.cdc pandemic vaccine testing fda containment spread transmission
Stocks for a recession: which companies have historically done well during recessions or are likely to this time?
Last week the Bank of England forecast a recession starting this autumn that it now expects to be deeper and longer than previously assumed. It also expects…
Last week the Bank of England forecast a recession starting this autumn that it now expects to be deeper and longer than previously assumed. It also expects inflation to hit 13% by the end of the year just months after reassuring that it didn’t expect more than modestly high figures.
Having belatedly acknowledged the extent of the inflation problem, admittedly exacerbated by the impact on energy and food prices the war in Ukraine has had, the UK’s central bank’s nine-member Monetary Policy Committee voted to raise interest rates. Thursday’s 0.5 percentage points rise, which took the BoE’s base rate to 1.75%, was the biggest single increase in 27 years.
The European Central Bank and USA’s Federal Reserve have also taken aggressive measures on rates, with the former also raising rates by 0.5% to 0%. It was the ECB’s first rates rise in 11 years. The Fed went even further, raising rates for the fourth and largest time this year with a 0.75 percentage points hike to between 2.25% and 2.5%.
Aggressive interest rate hikes alongside high levels of inflation tend to result in recession with the combination referred to as stagflation. With inflation expected to remain high next year and not dropping back towards the target 2% before 2023, we could be in for an extended period of recession.
Why stock markets fall during a recession but not all stocks do
Stock markets historically do badly during recessions for the simple reason they are a proxy for the economy and economic activity. When economic activity drops, people and companies have less money or are worried about having less money, so they spend less and companies earn less. Investors also become less optimistic about their prospects and valuations drop.
But the kind of drop in economic activity that leads to recessions is not evenly distributed across all areas of an economy. When consumers cut back on spending, they typically choose to sacrifice some things and not others, rather than applying an even haircut across all costs. And there are goods and services that people spend more on rather than less when tightening their belts.
So while the net impact of a recession has always historically been the London Stock Exchange and other major international stock markets losing market capitalisation, or value, that doesn’t mean all the stocks that constitute them go down. Some go down by more than others. And some stocks grow in value because the companies sell the categories of goods and services people spend more on when they are either poorer or worried about becoming poorer.
Should we be investing “for” a recession?
This surely means all investors need to do to mitigate against a recession is to sell out of the stocks that do badly during an economic slump and buy into those that do well? In theory, yes. In practice, doing that successfully would mean being sure a recession will take place some time before it becomes a reality and timing its onset, then the subsequent recovery, well.
That is of course far easier said than done which is why even professional fund managers don’t attempt the kind of comprehensive portfolio flip that would involve. Some investors will make big bets on events like the onset of a recession or inflation spiralling out of control.
They are the kind of bets that make for dramatic wins like those portrayed in the Hollywood film The Big Crash, which tells the story of a group of traders who predicted and bet big on the 2007 subprime mortgage implosion that triggered the international financial crisis. But as the film relies on for its dramatic tension, the big winners of The Big Crash very nearly got their timing wrong. Another few days and they would have been forced to close their positions just before market conditions turned in their favour and lost everything.
The reality is the big, risky bets that result in spectacular investment wins when they come off are usually far more likely to go wrong than right. Which is why regular investors, rather than high risk traders using leverage, shouldn’t take them. At least not with their main investment portfolio if they don’t have the luxury of being able to justify setting aside 10% to 20% of capital for highr isk-high reward bets.
If you have a well-balanced investment portfolio with a long term horizon and you are happy with the overall quality of your investments, you may choose to do nothing at all to mitigate against the recession that is almost certainly coming. If you have ten years or more until you expect to start drawing down an income from your portfolio, your investments should have plenty of time to recover from this period.
But if you do want to rebalance because you feel your portfolio is generally too heavily weighted towards the kind of growth stocks particularly vulnerable to inflation, higher interest rates and recession, you might want to consider rotating some of your capital into the kind of stocks that might do well in a recession.
How to pick stocks that will do well in a recession?
There are two ways to highlight stocks that might do well in a recession. The first is the most obvious and simplest approach – look at which did well in previous recessions. We had a very brief recession at the start of the Covid-19 pandemic and a much more significant one in 2008/09 in the wake of the international financial crisis. Which companies did well over those periods?
The second approach is to add a layer of complexity into the equation and consider how and why the coming recession might differ from the two most recent historical examples. The 2020 recession was extremely unusual in its brevity. Within a couple of months, stock markets were soaring again as people under quarantine and social distancing restrictions spent more in the digital economy and generally on services and products to enhance their experience being couped up at home.
The 2008/09 recession was also different because it was caused by a systemic failure in the financial sector. Unemployment leapt which is not expected to happen this time around with an especially tight labour market one result of the combination of the pandemic and Brexit. Many households also have higher levels of savings built up during the pandemic which a significant number of analysts believe is softening the impact of inflation.
While there are likely to be constants throughout recessions, there are also differences that should be taken into account. Normally energy companies do badly during a recession as lower economic activity means less energy being used. But energy companies are currently posting record profits because of sky-high energy prices which are one of the major factors behind the expected recession. They should continue to do well while the recession lasts as energy prices dropping again is likely to be one of the catalysts behind the recovery.
The online trading company eToro recently published two baskets of “recession winning stocks” – one made up of Wall Street-listed companies and the other companies listed in the UK. The stocks in each basket were selected because they were the biggest gainers during the last two recessions. Interestingly, they also did well during the intervening period between 2009 and 2020, as well as in the aftermath of the coronavirus crash.
The portfolio of US stocks beat the S&P 500 index of large American businesses by 60 percentage points through the financial crisis between 2007 and 2009 and by 9 percentage points during the Covid crisis in 2020.
The portfolio of UK stocks beat FTSE-100 by 35 percentage points during the financial crisis and by 17 percentage points in the Covid crash. Since 2007, the US portfolio has gained 834%, more than twice the return of the Nasdaq and about five times that of the S&P 500. The UK portfolio’s 129% return is eight times more than the FTSE 100’s, excluding dividends.
“Well represented segments included discount and everyday-low-price retailers as consumers trade down, like Walmart (WMT), Ross Stores (ROST) and Dollar Tree (DLTR).”
“Fast food McDonalds (MCD) is related. Similarly, home DIY, like Home Depot (HD) Lowe’s (LOWE), and auto repair parts stocks Autozone (AZO) and O’Reilly (ORLY). Health care and big biotech is well-represented as inelastic non-discretionary purchases, like Abbott (ABT), Amgen (AMGN), Vertex (VRTX).”
“Also, domestic comforts from toys (Hasbro, HAS) to candy (Hershey, HSY), and getting more from your money and tax (H&R Block, HRB), and educating yourself (2U, TWOU).”
The UK portfolio included the drug makers AstraZeneca and GlaxoSmithKline, which did well because spending money on healthcare and medicines is essential and families don’t tend to cut back even when struggling financially.
The cigarette makers British American Tobacco and Imperial Brands also don’t usually see any downturn in demand because they benefit from a customer base addicted to their products. Both companies pay high and rising dividends. Consumer goods firms such as Unilever and Premier Foods also typically do well because they own strong brands that people bought even after price rises have been passed on.
Proactive Investor also picks out a range of London-listed stocks it expects to do well over the next year or so. In the energy sector that is doing so well at the moment it highlights Harbour Energy as a “core sector stock” and Diversified Energy Company as having “one of the lowest-risk free cash flow profiles in the sector”, while Energean (a client) provides “excellent visibility on multi-decade cash flows”.
Another difference to recent recessions could be how miners do during the one expected from autumn. Normally lower economic activity reduces for demand for commodities but the sector is also facing supply constraints that should see prices supported or rebound quickly.
Copper, mineral sands and diamonds look among the commodities most constrained in terms of supply, with limited supply growth under development. Mining and commodity stocks to look at are suggested as:
“Atalaya Mining (AIM:ATYM, TSX:AYM), Central Asia Metals, Kenmare Resources, Petra Diamonds and Antofagasta, with Tharisa PLC (LSE:THS, JSE:THA) tagged on as platinum group output to be in focus as automotive sales recover.”
“Gold stocks are seen as outperforming the market during the pullback phase, as in March 2020 and in the initial stages of a rebound, with top picks currently Pan African Resources PLC (AIM:PAF, OTCQX:PAFRY, JSE:PAN, OTCQX:PAFRF), Pure Gold Mining Inc (TSX-V:PGM, LSE:PUR, OTC:LRTNF), Wheaton Precious Metals and Yamana Gold (TSX:YRI, LSE:AUY).”
Credit Suisse has also picked out stocks that have historically outperformed during recessions, highlighting:
“London Stock Exchange Group PLC (LSE:LSEG), RELX PLC (LSE:REL), Experian (LSE:EXPN) PLC, Microsoft Corporation (NASDAQ:MSFT) and Visa Inc (NYSE:V).”
While there is nothing wrong with doing some periodic portfolio rebalancing and potentially rotating more assets into stocks seen as likely to thrive in a recession, don’t panic. Recessions have always come and gone as part of the economic cycle and stock markets traditionally go on to greater heights during the subsequent recovery.
That means the chances are your portfolio will regain its losses and add new gains over the years ahead. Buying cheap growth stocks seen as likely candidates to flourish again during the recovery could be seen as just as sensible a tactic as rotating into recession-proof stocks. But if you do decide to reposition to some extent, look for stocks that have not only historically done well during recessions, or could be expected to during this one ahead, but are also healthy companies you would expect to keep doing well when markets recover. Then your success won’t come down to the fickle fate of whether or not you get your timing right.
TDR’s U.S. Stock Market Preview For The Week Of August 8, 2022
A weekly stock market preview and the data that will impact the tape. Sunday Evening Futures Open – Stock Market Preview Weekend News And Developments…
A weekly stock market preview and the data that will impact the tape.
Sunday Evening Futures Open – Stock Market Preview
Weekend News And Developments
Berkshire Hathaway dramatically slowed new investment in the second quarter after setting a blistering pace at the start of the year, as the US stock market sell-off pushed the insurance-to-railroad conglomerate to a $43.8bn loss.
China’s southern island province of Hainan started mass Covid-19 testing on Sunday, locking down more parts of the province of over 10 million residents, as authorities scramble to contain multiple Omicron-driven outbreaks, including the worst in capital Sanya, often called “China’s Hawaii”.
Cuba: 17 missing, 121 injured as fire rages in oil tank farm in Matanzas City
Equity positioning for both discretionary and systematic investors remains in the 12th percentile of its range since January 2010, according to Deutsche Bank published last week.
Fisker Inc. (NYSE:FSR) unveils a process for qualifying US-based reservation holders of the Fisker Ocean all-electric SUV to retain access to the existing federal tax credit. The current $7,500 tax credit would be unavailable should Congress pass the Inflation Reduction Act of 2022 and President Biden signs the legislation into law.
Former Labour prime minister Gordon Brown has called for an emergency budget before the UK hits a “financial timebomb” this autumn. Mr. Brown said millions would be pushed “over the edge” if the government does not address the cost of living crisis.
Israel said Sunday it killed a senior Islamic Jihad commander in a crowded Gaza refugee camp, the second such targeted attack since launching its high-stakes military offensive against the militant group just before the weekend. The Iran-backed militant group has fired hundreds of rockets at Israel in response, raising the risk of the cross-border fighting turning into a full-fledged war.
Rhine river hit by drought conditions, hampers German cargo shipping. According to reports, transport prices have shot up as drought and hot weather have affected water levels in the river Rhine in Germany leading cargo vessels to reduce loads during transportation.
Taiwan’s defense ministry said it had detected 66 Chinese air force planes and 14 Chinese warships conducting activities in and around the Taiwan Strait on Sunday, Reuters reports. Thursday’s drills involved the live firing of 11 missiles.
Unifor: 1,800 members from across the country arrive in Toronto this weekend before Monday’s start to the union’s 4th Constitutional Convention, where delegates will elect a new National President and vote on key priorities and initiatives. Unifor is Canada’s largest union in the private sector, representing 315,000 workers in every major area of the economy.
U.S. rate futures have priced in a 69% chance of a 75 bps hike at its September meeting, up from about 41% before the payrolls data. Futures traders have also factored in a fed funds rate of 3.57% by the end of the year.
What The Analysts Are Saying…
Anybody that jumped on the ‘Fed is going to pivot next year and start cutting rates’ is going to have to get off at the next station, because that’s not in the cards. It is clearly a situation where the economy is not screeching or heading into a recession here and now.” — Art Hogan, chief market strategist at B. Riley Financial
“It is not a market bottom, things are not going to go up consistently from here because we are going to be buying low tech products for a while, so everyone has something to make up as COVID demand = pre-COVID, there are fewer units for this. Reality check – unlike ‘Big Tech’, consumer discretionary related companies are offering more cautious guidance.” — Morgan Stanley analyst commentary on a potential market bottom
“The fact of the matter is this (Aug. 5 nonfarm payroll report) gives the Fed additional room to continue to tighten, even if it raises the probability of pushing the economy into recession. It’s not going to be an easy task to continue to tighten without negative repercussions for the consumer and the economy”. — Jim Baird, chief investment officer at Plante Moran Financial Advisors
“We are surprised to not see investors start to chase upside calls in fear of underperforming the market. People are just watching.” — Matthew Tym, head of equity derivatives trading at Cantor Fitzgerald
What We’re Watching
• Psychedelic Sector Gaining Momentum: What started out as bottoming action after a protracted multi-quarter decline has now morphed into a tangible bullish impulse. We believe Netflix new docuseries How To Change Your Mind has played an important roll in the creation of critical mass awareness for the sector—and a rebound in broad market risk assets hasn’t hurt. At the tip of the spear for this sentiment shift is COMPASS Pathways plc (CMPS), which has risen 62.64% since the docuseries debuted on July 12. Price on the benchmark Horizons Psychedelic Stock Index ETF has now breached the 20-day MA/EMA.
We are watching to see if investor sentiment shifts into laggard names such as Cybin Inc. and MindMed, which has continued to fall following a proposed 15-1 reverse stock split initiative announced this year. Many Tier-2/3 names still 90%+ off their highs…
• Revive Therapeutics (RVV:CSE, RVVTF:OTC): This has been on our radar for the last couple of weeks, and remains on our watch list. The company has already confirmed that their statistician is in possession of 210 unblinded patient data for its Phase 3 clinical trial to evaluate Bucillamine to treat COVID-19. The company is currently attempting to revise endpoint data from a hospitalization/death focus to a symptoms focus. If they are to achieve this, it will mark a material event in the course of the trial.
We believe an endpoint decision, either positive or negative, is imminent and will have cause a material price action event.
• Consumer Price Index, August 10: Consumer inflation expectations for July are released by the New York Fed, while the University of Michigan’s preliminary survey of consumers for August is on tap. Taken together, these should give investors a better picture of how consumers are feeling about current economic conditions.
As of June, it’s running at 9.1% on an annual basis. Investors, economists and consumers will be watching to see if price increases are easing as everything from gasoline to food is elevated.
Given the mixed signals on the overall state of the economy (i.e. indications of recession vs. this week’s strong nonfarm payrolls number), CPI will be in-focus by market participants. Scotiabank expects 8.9% y/y (9.1% prior) and 0.4% m/m for headline CPI; ex-food-and-energy: 6.1% y/y led by a 0.6% m/m gain.
• Pot stocks earnings continue, with several Tier-1/Teri-2 names reporting including Curaleaf Holdings, Trulieve Cannabis, Marimed Inc., Cronos Group, TerrAscend Corp. and more. Last Wednesday, Green Thumb Industries allayed fears somewhat that this earnings season would be a write-off, producing solid numbers which beat expectations on several key metrics. An additional strong report or two will go a long way to help improve sentiment for a sector that’s been decimated over the past six quarters.
U.S. Economic Calendar
|TIME (ET)||REPORT||PERIOD||MEDIAN FORECAST||PREVIOUS|
|Monday, August 8|
|11:00 AM||NY Fed 3-year inflation expectations||July||—||3.60%|
|Tuesday, Aug. 9|
|6:00 AM||NFIB small-business index||July||89.5||89.5|
|8:30 AM||Unit labor costs||Q2||9.30%||12.60%|
|Wednesday, August 10|
|8:30 AM||Consumer price index||July||0.30%||1.30%|
|8:30 AM||Core CPI||July||0.60%||0.70%|
|8:30 AM||CPI (year-over-year)||July||-8.70%||9.10%|
|8:30 AM||Core CPI (year-over-year)||July||6.10%||5.90%|
|10:00 AM||Wholesale inventories (revision)||June||1.90%||1.70%|
|2:00 PM||Federal budget (compared with year earlier)||July||—||-$302 billion|
|Thursday, August 11|
|8:30 AM||Initial jobless claims||Aug. 6||265,000||260,000|
|8:30 AM||Continuing jobless claims||July 30||—||1.42 million|
|8:30 AM||Producer price index||July||0.20%||1.10%|
|Friday, Aug. 12|
|8:30 AM||Import price index||July||-0.80%||0.20%|
|10:00 AM||UMich consumer sentiment index (preliminary)||Aug.||53||52|
|10:00 AM||UMich 5-year inflation expectations (preliminary)||Aug.||—||2.90%|
Meme Of The Week
Key Earnings (US Markets)
|Monday, August 8||3D Systems||DDD||$0.00 per share|
|Take-Two Interactive Software||TTWO||$0.86|
|Tuesday, Aug. 9||Akamai Technologies||AKAM||$1.31|
|H & R Block||HRB||$1.24|
|Hilton Grand Vacations||HGV||$0.88|
|Norwegian Cruise Line||NCLH||-$0.83|
|Super Micro Computer||SMCI||$2.35|
|The Trade Desk||TTD||$0.20|
|Warner Music Group||WMG||$0.20|
|World Wrestling Entertainment||WWE||$0.55|
|Wednesday, August 10||AppLovin||APP||$0.50|
|Jack in the Box||JACK||$1.42|
|Pan Am Silver||PAAS||$0.14|
|Red Robin Gourmet||RRGB||-$0.16|
|Wolverine World Wide||WWW||$0.65|
|Thursday, August 11||AerCap||AER||$1.42|
|Brookfield Asset Management||BAM||$0.69|
|Melco Resorts & Entertainment||MLCO||-$0.44|
|Ryan Specialty Group||RYAN||$0.35|
|Wheaton Precious Metals||WPM||$0.32|
|Friday, Aug. 12||Broadridge Financial||BR||$2.65|
Past Week What’s Hot… and What’s Not
Top 12 High Short Interest Stocks
|BBBY||Bed Bath & Beyond Inc.||Nasdaq||46.38%||61.57M||79.96M||Retail (Specialty Non-Apparel)|
|ICPT||Intercept Pharmaceuticals Inc||Nasdaq||43.76%||23.62M||29.71M||Biotechnology & Medical Research|
|MSTR||MicroStrategy Inc||Nasdaq||39.29%||9.32M||9.33M||Software & Programming|
|BYND||Beyond Meat Inc||Nasdaq||37.91%||56.79M||63.54M||Food Processing|
|SWTX||SpringWorks Therapeutics Inc||Nasdaq||37.51%||31.64M||49.41M||Biotechnology & Medical Research|
|BIG||Big Lots, Inc.||NYSE||37.37%||26.49M||28.92M||Retailers – Discount Stores|
|EVGO||Evgo Inc||Nasdaq||35.65%||67.76M||69.00M||Utilities – Electric|
|UPST||Upstart Holdings Inc||Nasdaq||35.60%||72.32M||84.77M||Consumer Lending|
|BGFV||Big 5 Sporting Goods Corp||Nasdaq||34.65%||20.85M||22.33M||Retailers – Miscellaneous Specialty|
|SRG||Seritage Growth Properties||NYSE||34.38%||23.58M||43.68M||Real Estate Operations|
|NKLA||Nikola Corporation||Nasdaq||32.77%||265.95M||421.14M||Auto & Truck Manufacturers|
|BLNK||Blink Charging Co||Nasdaq||32.54%||33.98M||50.20M||Utilities – Electric|
Tags: stock market preview, stock market preview August 8, 2022.
The post TDR’s U.S. Stock Market Preview For The Week Of August 8, 2022 appeared first on The Dales Report.recession consumer sentiment covid-19 tsx stocks fed etf otc congress senate testing fda recession oil iran canada uk germany china
US University Admits It May Have Broken Law In Contract With Wuhan Lab
UK Gas Crisis Set To Plunge British Pound To Historic Lows, UBS Warns
Shareholders Only Booed Elon Musk Once — When he Said This
Doctors Criticize Fauci For Saying COVID Vaccines Induce ‘Only Temporary’ Menstrual Irregularities
Why Did Elon Musk Get Booed at Tesla’s Event?
Which Nations Face The Biggest Disruption From China’s Taiwan-Trade-Blockade?
TDR’s U.S. Stock Market Preview For The Week Of August 8, 2022
This Week in Apps: French developers sue Apple, time spent in apps grows, Instagram adds NFTs
Indiana Enacts Near Total Abortion Ban
Government9 hours ago
TDR’s U.S. Stock Market Preview For The Week Of August 8, 2022
Government12 hours ago
Senate Passes $740 Billion Tax, Climate Package — Will Go To House Next
Government14 hours ago
UN Warns Of ‘Worrying And Dangerous’ Conspiracy Theories
Science13 hours ago
Regen BioPharma Inc (OTCMKTS: RGBP) Breaking Out as Biotech Files Patent on Dendritic Cell Technologies to Augment Efficacy of Survivin mRNA Cancer Immunotherapeutic Vaccine
Economics12 hours ago
Aura High Yield SME Fund: Letter to Investors 05 August 2022
Government15 mins ago
Here We Go Again – Monkeypox Communications Challenges
Spread & Containment4 hours ago
Fatigue, headache among top lingering symptoms months after COVID
Spread & Containment45 mins ago
Stocks for a recession: which companies have historically done well during recessions or are likely to this time?